Inmode (INMD) has released an update.
InMode Ltd., a leading medical technology provider, has reported a 24% year-over-year decrease in quarterly revenue to $80.3 million for Q1 2024, with a GAAP net income drop to $23.7 million from $40.5 million in Q1 2023. Despite these declines, the company has launched a share repurchase program to buy back up to 8.37 million shares and appointed Dr. Michael Anghel as the new Chairman of the Board.
For further insights into INMD stock, check out TipRanks’ Stock Analysis page.
